Global Insulin Injection Pen Market

Insulin Injection Pen Comprehensive Study by Type (Disposable cartridge Insulin Pens, Reusable cartridge Insulin Pens), Application (Hospital, Diabetes Clinics/ Centers, Home) Players and Region - Global Market Outlook to 2030

Insulin Injection Pen Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Insulin Pen is a pen used to inject insulin for the treatment of diabetes patients. The sleek design & compact size of insulin allows to easily deliver insulin anywhere by measuring & delivering from 0.5 to 80 units of insulin at a time. The maximum dose & the incremental amount vary depending upon the type of insulin pen being used. The insulin pen with its design allows accurate, simplified & convenient delivery. The insulin pen which are equipped & have auto shield needle may offer greater accuracy while injecting a dose. Insulin pens are easy to use and preferable for older people having diabetes. Insulin pen has ability to fine tune & deliver highly accurate doses with portable, discreet & convenient nature of pen. Insulin pen have small & thin needle size which reduces the pain & fear for injecting insulin. It is one of the time saving device with memory features as well to show when & how much the last dose was. As the insulin pens are equipped with pre-filled & replaceable needle features, preference for the insulin pen continue to remain high in global market. These pens may be reusable or disposable. Disposable pen contain a pre-filled insulin cartridge which is thrown away when the cartridge is empty and this cartridge easily disposable. The reusable pen contain a replaceable insulin cartridge. Once the cartridge is empty it may be discarded & put the new cartridge for use. According to AMA Research, the market for Insulin Injection Pen is expected to register a CAGR of 7.2% during the forecast period to 2030. This growth is primarily driven by Easy to carry as portable & available in compact size .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Medical Devices sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Becton Dickinson (United States), Novo Nordisk (Denmark), B. Braun Melsungen (Germany), Spirit Healthcare (United Kingdom), Terumo Corporation (Japan), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Biocorp (France), Dongbao Enterprise Group Co., Ltd. (China), Allison Medical (United States), UltiMed Inc. (United States), Shanghai Beipu Medical Co. Ltd. (China) and HTL-STREFA (Poland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 11th August 2020, Medtronic plc the global leader in medical technology announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app on the market. The addition of Companion Medical’s InPen to the Medtronic portfolio expands the company’s ability to serve people where they are in their diabetes journey and offer them a unique and expansive ecosystem of support — regardless of how insulin is delivered.
On 13th April 2021, BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France. Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers patients with diabetes better compliance with their treatment, according to the companies.The Insulin Injection Pen companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Regulatory Insights:
FDA's Center for Devices & Radiological Health (CDRH) is responsible for regulating firms that manufacture, repackage, relabel, &/or import medical devices. Food & Drug Administration (FDA) & World Health Organization (WHO) are providing the guidelines regarding the risk associated with medical devices to ensure patient safety & to check the effectiveness of the devices.

Influencing Trend:
Reusable insulin pens i.e. replaceable cartridge and Other infusion devices are becoming technologically advanced

Market Growth Drivers:
Easy to carry as portable & available in compact size, Shows accuracy in measuring & delivering insulin, Ease of usability, Provision of data regarding last dose, Replaceable needles & cartridge increases lifespan of product and Low cost

Challenges:
strict government rules for new products development

Restraints:
customers are becoming more conscious regarding safety issues

Opportunities:
Increasing arrival of diabetes in various age groups, Inclination of the customers towards Time saving device due to busy life and Emergence of affordable devices for such a common disease like diabetes

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Insulin Injection Pen Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Insulin Injection Pen Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Insulin Injection Pen players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Insulin Injection Pen Study Sheds Light on
— The Insulin Injection Pen Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Insulin Injection Pen industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Insulin Injection Pen industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Disposable cartridge Insulin Pens
  • Reusable cartridge Insulin Pens
By Application
  • Hospital
  • Diabetes Clinics/ Centers
  • Home
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Easy to carry as portable & available in compact size
      • 3.2.2. Shows accuracy in measuring & delivering insulin
      • 3.2.3. Ease of usability
      • 3.2.4. Provision of data regarding last dose
      • 3.2.5. Replaceable needles & cartridge increases lifespan of product
      • 3.2.6. Low cost
    • 3.3. Market Challenges
      • 3.3.1. Strict government rules for new products development
    • 3.4. Market Trends
      • 3.4.1. Reusable insulin pens i.e. replaceable cartridge
      • 3.4.2. Other infusion devices are becoming technologically advanced
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Insulin Injection Pen, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Insulin Injection Pen (Value)
      • 5.2.1. Global Insulin Injection Pen by: Type (Value)
        • 5.2.1.1. Disposable cartridge Insulin Pens
        • 5.2.1.2. Reusable cartridge Insulin Pens
      • 5.2.2. Global Insulin Injection Pen by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Diabetes Clinics/ Centers
        • 5.2.2.3. Home
      • 5.2.3. Global Insulin Injection Pen Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Insulin Injection Pen: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novo Nordisk (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Spirit Healthcare (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Terumo Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ypsomed Holding AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic plc (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biocorp (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Dongbao Enterprise Group Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Allison Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. UltiMed Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Shanghai Beipu Medical Co. Ltd. (China)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. HTL-STREFA (Poland)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Insulin Injection Pen Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Insulin Injection Pen (Value)
      • 7.2.1. Global Insulin Injection Pen by: Type (Value)
        • 7.2.1.1. Disposable cartridge Insulin Pens
        • 7.2.1.2. Reusable cartridge Insulin Pens
      • 7.2.2. Global Insulin Injection Pen by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Diabetes Clinics/ Centers
        • 7.2.2.3. Home
      • 7.2.3. Global Insulin Injection Pen Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Insulin Injection Pen: by Type(USD Million)
  • Table 2. Insulin Injection Pen Disposable cartridge Insulin Pens , by Region USD Million (2018-2023)
  • Table 3. Insulin Injection Pen Reusable cartridge Insulin Pens , by Region USD Million (2018-2023)
  • Table 4. Insulin Injection Pen: by Application(USD Million)
  • Table 5. Insulin Injection Pen Hospital , by Region USD Million (2018-2023)
  • Table 6. Insulin Injection Pen Diabetes Clinics/ Centers , by Region USD Million (2018-2023)
  • Table 7. Insulin Injection Pen Home , by Region USD Million (2018-2023)
  • Table 8. South America Insulin Injection Pen, by Country USD Million (2018-2023)
  • Table 9. South America Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 10. South America Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 11. Brazil Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 12. Brazil Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 13. Argentina Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 14. Argentina Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 15. Rest of South America Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Insulin Injection Pen, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 20. China Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 21. China Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 22. Japan Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 23. Japan Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 24. India Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 25. India Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 26. South Korea Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 27. South Korea Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 28. Taiwan Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 29. Taiwan Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 30. Australia Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 31. Australia Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 34. Europe Insulin Injection Pen, by Country USD Million (2018-2023)
  • Table 35. Europe Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 36. Europe Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 37. Germany Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 38. Germany Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 39. France Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 40. France Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 41. Italy Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 42. Italy Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 43. United Kingdom Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 45. Netherlands Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 46. Netherlands Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 49. MEA Insulin Injection Pen, by Country USD Million (2018-2023)
  • Table 50. MEA Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 51. MEA Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 52. Middle East Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 53. Middle East Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 54. Africa Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 55. Africa Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 56. North America Insulin Injection Pen, by Country USD Million (2018-2023)
  • Table 57. North America Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 58. North America Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 59. United States Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 60. United States Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 61. Canada Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 62. Canada Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 63. Mexico Insulin Injection Pen, by Type USD Million (2018-2023)
  • Table 64. Mexico Insulin Injection Pen, by Application USD Million (2018-2023)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Insulin Injection Pen: by Type(USD Million)
  • Table 79. Insulin Injection Pen Disposable cartridge Insulin Pens , by Region USD Million (2025-2030)
  • Table 80. Insulin Injection Pen Reusable cartridge Insulin Pens , by Region USD Million (2025-2030)
  • Table 81. Insulin Injection Pen: by Application(USD Million)
  • Table 82. Insulin Injection Pen Hospital , by Region USD Million (2025-2030)
  • Table 83. Insulin Injection Pen Diabetes Clinics/ Centers , by Region USD Million (2025-2030)
  • Table 84. Insulin Injection Pen Home , by Region USD Million (2025-2030)
  • Table 85. South America Insulin Injection Pen, by Country USD Million (2025-2030)
  • Table 86. South America Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 87. South America Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 88. Brazil Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 89. Brazil Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 90. Argentina Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 91. Argentina Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 92. Rest of South America Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 93. Rest of South America Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 94. Asia Pacific Insulin Injection Pen, by Country USD Million (2025-2030)
  • Table 95. Asia Pacific Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 96. Asia Pacific Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 97. China Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 98. China Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 99. Japan Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 100. Japan Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 101. India Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 102. India Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 103. South Korea Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 104. South Korea Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 105. Taiwan Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 106. Taiwan Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 107. Australia Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 108. Australia Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 109. Rest of Asia-Pacific Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 110. Rest of Asia-Pacific Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 111. Europe Insulin Injection Pen, by Country USD Million (2025-2030)
  • Table 112. Europe Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 113. Europe Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 114. Germany Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 115. Germany Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 116. France Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 117. France Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 118. Italy Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 119. Italy Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 120. United Kingdom Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 121. United Kingdom Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 122. Netherlands Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 123. Netherlands Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 124. Rest of Europe Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 125. Rest of Europe Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 126. MEA Insulin Injection Pen, by Country USD Million (2025-2030)
  • Table 127. MEA Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 128. MEA Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 129. Middle East Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 130. Middle East Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 131. Africa Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 132. Africa Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 133. North America Insulin Injection Pen, by Country USD Million (2025-2030)
  • Table 134. North America Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 135. North America Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 136. United States Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 137. United States Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 138. Canada Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 139. Canada Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 140. Mexico Insulin Injection Pen, by Type USD Million (2025-2030)
  • Table 141. Mexico Insulin Injection Pen, by Application USD Million (2025-2030)
  • Table 142. Research Programs/Design for This Report
  • Table 143. Key Data Information from Secondary Sources
  • Table 144. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Injection Pen: by Type USD Million (2018-2023)
  • Figure 5. Global Insulin Injection Pen: by Application USD Million (2018-2023)
  • Figure 6. South America Insulin Injection Pen Share (%), by Country
  • Figure 7. Asia Pacific Insulin Injection Pen Share (%), by Country
  • Figure 8. Europe Insulin Injection Pen Share (%), by Country
  • Figure 9. MEA Insulin Injection Pen Share (%), by Country
  • Figure 10. North America Insulin Injection Pen Share (%), by Country
  • Figure 11. Global Insulin Injection Pen share by Players 2023 (%)
  • Figure 12. Global Insulin Injection Pen share by Players (Top 3) 2023(%)
  • Figure 13. Global Insulin Injection Pen share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 16. Becton Dickinson (United States) Revenue: by Geography 2023
  • Figure 17. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 18. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 19. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 20. B. Braun Melsungen (Germany) Revenue: by Geography 2023
  • Figure 21. Spirit Healthcare (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Spirit Healthcare (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 25. Ypsomed Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Ypsomed Holding AG (Switzerland) Revenue: by Geography 2023
  • Figure 27. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 29. Biocorp (France) Revenue, Net Income and Gross profit
  • Figure 30. Biocorp (France) Revenue: by Geography 2023
  • Figure 31. Dongbao Enterprise Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 32. Dongbao Enterprise Group Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 33. Allison Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Allison Medical (United States) Revenue: by Geography 2023
  • Figure 35. UltiMed Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. UltiMed Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Shanghai Beipu Medical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 38. Shanghai Beipu Medical Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 39. HTL-STREFA (Poland) Revenue, Net Income and Gross profit
  • Figure 40. HTL-STREFA (Poland) Revenue: by Geography 2023
  • Figure 41. Global Insulin Injection Pen: by Type USD Million (2025-2030)
  • Figure 42. Global Insulin Injection Pen: by Application USD Million (2025-2030)
  • Figure 43. South America Insulin Injection Pen Share (%), by Country
  • Figure 44. Asia Pacific Insulin Injection Pen Share (%), by Country
  • Figure 45. Europe Insulin Injection Pen Share (%), by Country
  • Figure 46. MEA Insulin Injection Pen Share (%), by Country
  • Figure 47. North America Insulin Injection Pen Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton Dickinson (United States)
  • Novo Nordisk (Denmark)
  • B. Braun Melsungen (Germany)
  • Spirit Healthcare (United Kingdom)
  • Terumo Corporation (Japan)
  • Ypsomed Holding AG (Switzerland)
  • Medtronic plc (Ireland)
  • Biocorp (France)
  • Dongbao Enterprise Group Co., Ltd. (China)
  • Allison Medical (United States)
  • UltiMed Inc. (United States)
  • Shanghai Beipu Medical Co. Ltd. (China)
  • HTL-STREFA (Poland)
Additional players considered in the study are as follows:
Owen Mumford (United States) , Jiangsu Delfu medical device (China) , Sanofi (France) , Eli Lilly (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 218 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Insulin Injection Pen Market Quantitative research analysis
Global Insulin Injection Pen Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Insulin Injection Pen Market are Becton Dickinson (United States), Novo Nordisk (Denmark), B. Braun Melsungen (Germany), Spirit Healthcare (United Kingdom), Terumo Corporation (Japan), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Biocorp (France), Dongbao Enterprise Group Co., Ltd. (China), Allison Medical (United States), UltiMed Inc. (United States), Shanghai Beipu Medical Co. Ltd. (China) and HTL-STREFA (Poland) etc.
Hospital segment in Global market to hold robust market share owing to "Easy to carry as portable & available in compact size ".
AMA Research predicts that United states and European Players will contribute to the maximum growth of Global Insulin Injection Pen market throughout the forecasted period.

Know More About Global Insulin Injection Pen Market Report?

Have a Query? Click Here

Other Related Reports

Medical Syringe Comprehensive Study by Type (Non-Disposable Syringes, Disposable Syringes (Safety Syringes, Conventional Syringes)), Application (Hospital, Clinic, Others), Distribution Channel (Onli...
$ 3500
Rigid Endoscope Comprehensive Study by Type (Global Straight-Rigid Endoscopes, Global Semi-Rigid Endoscopes), Application (Laparoscopy, Arthroscopy, Gastrointestinal endoscopy, Gynecology endoscopy, ...
$ 3750
Germicidal Lamps Comprehensive Study by Type (Low Pressure Lamps, High Pressure Lamps), Application (Biology Laboratories, Hospitals, Agricultural and Food Industry, Others) Players and Region - Glob...
$ 3500
Nursing Home Beds Comprehensive Study by Distribution Channel (Online Channel, Offline Channel), Operation (Manual, Electric) Players and Region - Global Market Outlook to 2026
$ 3500
Nitinol Stone Basket Comprehensive Study by Type (3-Wire, 4-Wire, 6-Wire), Application (Flexible Ureteroscopy, Semi-rigid Ureteroscopy), Tip (With Tip, Without Tip), End User (Hospitals, Specialty Cl...
$ 3350
Veterinary Ultrasound Scanners Comprehensive Study by Type (Portable System, Bench-top System), Application (Livestock, Pet, Other), Technology (Digital Imaging, Contrast Imaging, Analog Imaging), Ul...
$ 3650